DrugDashboards

Amoxicillin and Clavulanate Potassium

amoxicillin and clavulanate potassium · AMOXICILLIN 562.5 mg/1; CLAVULANATE POTASSIUM 62.5 mg/1; AMOXICILLIN SODIUM 437.5 mg/1 · Tablet, Film Coated, Extended Release · Oral · USAntibiotics, LLC

NDC 81964-0220-28 · 28 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE · NDA AUTHORIZED GENERIC · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.50$5.00$7.50Apr 2026Sep 2026$5.83
6 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$175.02
#90 count
$525.05

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for amoxicillin and clavulanate potassium (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
NDA050785
TE code
AB
Approval date
Sep 25, 2002
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of amoxicillin and clavulanate potassium (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
USAntibiotics, LLCAMOXICILLIN 562.5 mg/1; CLAVULANATE POTASSIUM 62.5 mg/1; AMOXICILLIN SODIUM 437.5 mg/1Aug 26, 2026Sep 2, 2026
USAntibiotics, LLCAMOXICILLIN 562.5 mg/1; CLAVULANATE POTASSIUM 437.5 mg/1; AMOXICILLIN SODIUM 62.5 mg/1Jul 22, 2026Aug 19, 2026
USAntibiotics, LLCAMOXICILLIN 562.5 mg/1; AMOXICILLIN SODIUM 437.5 mg/1; CLAVULANATE POTASSIUM 62.5 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Amoxicillin and Clavulanate Potassium — NDC 81964-0220-28," retrieved September 3, 2026, https://drugdashboards.com/drug/81964022028.

Free to cite with attribution — see how the data is put together.